Surgery Partners to Sell Idaho Falls Hospitals to Intermountain Health for ~$795M
SGRY sits 38% above its 52-week low of $11.41.
Summary
Surgery Partners announced a definitive agreement to sell its Idaho Falls hospital facilities to Intermountain Health for approximately $795 million, marking a major step in its portfolio optimization strategy.
Key Events · M&A and Partnerships · SGRY
-
Sale of Idaho Falls Hospitals
Surgery Partners agreed to sell its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health for total consideration of approximately $795 million, valuing the combined facilities at $1.15 billion.
-
Financial Impact
The company expects substantial cash proceeds upon closing, though final net proceeds are subject to customary adjustments for indebtedness, working capital, and transaction expenses.
-
Closing Conditions
Completion is subject to physician member and governing board approvals, expiration of HSR waiting period, other regulatory approvals, and third-party consents. The transaction is expected to close in the coming months.
-
Guidance Reaffirmed
Excluding the impact of the transaction, Surgery Partners reaffirmed its 2026 revenue outlook of $3.35–$3.45 billion and Adjusted EBITDA of at least $530 million.
Analysis · SGRY · Industrial Applications And Services
Surgery Partners has entered into a binding agreement to sell its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health. The transaction values the combined facilities at approximately $1.15 billion, with Surgery Partners receiving total consideration of approximately $795 million. This is a significant portfolio optimization move, representing a major asset sale that will generate substantial cash proceeds, though final net proceeds are subject to adjustments. The deal is subject to physician approvals, regulatory clearances, and other customary closing conditions. The company also reaffirmed its 2026 guidance excluding the impact of the transaction, signaling confidence in its core operations. The sale sharpens the company's strategic focus on high-growth ambulatory surgery centers.
At the time of this filing, SGRY was trading at $15.70 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2B. The 52-week trading range was $11.41 to $24.10. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.